Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage
Clinical trial NCT03741530 · COMPLETED
Trial details
- NCT number
- NCT03741530
- Sponsor
- Xijing Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-15
- Primary completion
- 2020-09-23
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.